Estrogen and Tamoxifen Metabolites Protect Smooth Muscle Cell Membrane Phospholipids Against Peroxidation and Inhibit Cell Growth
- 5 February 1999
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 84 (2) , 229-239
- https://doi.org/10.1161/01.res.84.2.229
Abstract
—The goal of this study was to test the hypothesis that antioxidant estrogens, by a mechanism independent of the estrogen receptor, protect phospholipids residing in the plasma membrane of vascular smooth muscle cells from peroxidation and peroxidation-induced cell growth and migration. Peroxidation of membrane phospholipids was assessed by HPLC analysis of phospholipids extracted from rat aortic vascular smooth muscle cells prelabeled with cis-parinaric acid (a fatty acid that is susceptible to peroxidation, which quenches its fluorescent properties). Incubation of cells for 2 hours with the peroxyl radical donor 2,2′-azobis-2,4-dimethylvaleronitrile (AMVN) caused peroxidation of all measured membrane phospholipids. This effect was attenuated by pretreating cells for 15 minutes with 50 to 5000 ng/mL of 2-hydroxyestradiol (strong antioxidant but weak estrogen-receptor ligand) or 4-hydroxytamoxifen (strong antioxidant and potent estrogen-receptor ligand), but not by estrone or droloxifene (both weak antioxidants but potent estrogen-receptor ligands). Moreover, pretreatment of cells for 20 hours with physiological concentrations (0.3 ng/mL) of 2-hydroxyestradiol or pharmacologically relevant concentrations of 4-hydroxytamoxifen (40 ng/mL) also decreased AMVN-induced phospholipid peroxidation. Both 2-hydroxyestradiol and 4-hydroxytamoxifen were as effective as 2,2,5,7,8-pentamethyl-6-hydrochromane (an antioxidant homolog of vitamin E) in attenuating AMVN-induced peroxidation of membrane phospholipids. Also, physiological concentrations of 2-hydroxyestradiol, but not estrone, and pharmacologically relevant concentrations of 4-hydroxytamoxifen attenuated AMVM-induced DNA synthesis, cell proliferation, and cell migration. These studies demonstrate in vascular smooth muscle cells that antioxidant estrogens via a non-estrogen receptor–dependent mechanism attenuate peroxidation of membrane phospholipids and peroxidation-induced cell growth and migration.Keywords
This publication has 30 references indexed in Scilit:
- 17β-Estradiol, Its Metabolites, and Progesterone Inhibit Cardiac Fibroblast GrowthHypertension, 1998
- Non-random peroxidation of different classes of membrane phospholipids in live cells detected by metabolically integrated cis-parinaric acidBiochimica et Biophysica Acta (BBA) - Biomembranes, 1996
- Linoleic acid and its metabolites, hydroperoxyoctadecadienoic acids, stimulate c-Fos, c-Jun, and c-Myc mRNA expression, mitogen-activated protein kinase activation, and growth in rat aortic smooth muscle cells.Journal of Clinical Investigation, 1995
- Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cell. Role of cyclic-nucleotides and angiotensin1 receptors.Journal of Clinical Investigation, 1995
- Acyl-trafficking in membrane phospholipid fatty acid turnover: The transfer of fatty acid from the acyl-L-carnitine pool to membrane phospholipids in intact human erythrocytesBiochemical and Biophysical Research Communications, 1992
- Direct and continuous measurement of hydroperoxide-induced oxidative stress on the membrane of intact erythrocytesFree Radical Biology & Medicine, 1991
- Estrogens inhibit copper and cell-mediated modification of low density lipoproteinAtherosclerosis, 1991
- Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidencePreventive Medicine, 1991
- Patterns of coronary heart disease morbidity and mortality in the sexes: A 26-year follow-up of the Framingham populationPublished by Elsevier ,1986
- High performance liquid chromatographic separation and direct ultraviolet detection of phospholipidsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1977